NIGHT FEVER
LIVE

Serial Number

79154858

Owner

BIOFAR

Attorney

Mary Margaret L. O'Donnell

Filing Date

Aug 11, 2014

Add to watchlist:

No watchlists yet
View on USPTO

NIGHT FEVER Trademark

Serial Number: 79154858 • Registration: 4834034

NIGHT FEVER is a trademark filed by BIOFAR on August 11, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BIOFAR (7 trademarks)

6, rue des Marguerites
F-92000 NANTERRE , FR

Entity Type: 99

Trademark Details

Filing Date

August 11, 2014

Registration Date

October 20, 2015

Published for Opposition

August 4, 2015

Cancellation Date

May 6, 2022

Goods & Services

Pharmaceutical preparations for enhancing energy production in the body, parapharmaceutical preparations for enhancing energy production in the body, dietetic foods adapted for medical and paramedical use, namely, pasta and crackers, as well as dietary food supplements for medical or paramedical use, each of which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; pharmaceutical and parapharmaceutical preparations for enhancing energy production, all made from plants, extracts of plants, or vegetable extracts and available in effervescent or other forms; pharmaceutical and parapharmaceutical preparations for use as a treatment for enhancing energy production, all containing minerals or vitamins, and available in effervescent or other forms; vitamins and mineral supplements in effervescent or other forms; pharmaceutical and parapharmaceutical preparations, based on phytotherapy and for enhancing energy production; nutritional supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use, as additions to the nutrient intake in a normal diet, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; all dietetic foods supplements adapted for medical and paramedical use, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; nutritional supplements for medical use prepared for human consumption from food ingredients of vegetable or mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable or mineral origin, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients; fortifying nutritional food supplements adapted for medical use; fortifying nutritional food supplements adapted for paramedical use, and which contain one or more of the following substances, proteins, carbohydrates, lipids, fibers, micronutrients such as vitamins or minerals, amino acids or fatty acids, and available in the form of individual doses, such as capsules, effervescent tablets, non-effervescent tablets, sugar-coated tablets, gelatin capsules, sachets, chewing gum, dry extracts, powders, cellulose microspheres or granules, impregnated with active depurative ingredients

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 2, 2026 ADCH
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 6, 2023 INTR
REFUSAL PROCESSED BY IB
Dec 11, 2022 RFNT
CANCELLED SECTION 71
May 6, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 20, 2020 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 2, 2017 TCCA
INTERNATIONAL REGISTRATION RENEWED
Nov 3, 2016 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 1, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2016 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 20, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2015 R.PR
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 28, 2015 INNT
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 27, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2015 CRFA
ASSIGNED TO LIE
Jun 8, 2015 ALIE
ASSIGNED TO LIE
Jun 8, 2015 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 1, 2015 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 31, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 31, 2015 REAP
REFUSAL PROCESSED BY IB
Dec 26, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 3, 2014 RFCS
REFUSAL PROCESSED BY MPU
Dec 3, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2014 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 25, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 22, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2014 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 17, 2014 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 13, 2014 SDRC